share_log

Tonix Pharmaceuticals Presented Data On Its Potential Mpox Vaccine TNX-801 In "Using Synthetic Biology To Battle Mpox" Talk At Immunology Symposium At The University Of Alberta

Benzinga ·  Sep 9 07:11

Tonix Pharmaceuticals Presented Data On Its Potential Mpox Vaccine TNX-801 In "Using Synthetic Biology To Battle Mpox" Talk At Immunology Symposium At The University Of Alberta, TNX-801 Vaccination Demonstrated Efficacy In Protecting Animals From Lethal Challenge With Clade I Mpox

  • New data show improved tolerability in immunocompromised animals and no evidence of spreading to blood or tissues even at high doses

  • Tonix's synthetic horsepox vaccine platform has been selected by NIH's Project NextGen for clinical testing

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment